General Information of the Compound
| Compound ID |
CP0095010
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[5-[4-(2-fluorophenyl)piperazin-1-yl]pentyl]-3,5-dimethyl-5-phenylimidazolidine-2,4-dione;hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H33FN4O2
|
||||||||||||||||||
| Molecular Weight |
452.574
|
||||||||||||||||||
| Canonical SMILES |
CN1C(=O)N(CCCCCN2CCN(CC2)c2ccccc2F)C(C)(C1=O)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H33FN4O2.ClH/c1-26(21-11-5-3-6-12-21)24(32)28(2)25(33)31(26)16-10-4-9-15-29-17-19-30(20-18-29)23-14-8-7-13-22(23)27;/h3,5-8,11-14H,4,9-10,15-20H2,1-2H3;1H
Show/Hide
|
||||||||||||||||||
| InChIKey |
PRBFQLUJPVQDGH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7